Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA

Detalles Bibliográficos
Autores principales: Zhao, Xinmin, Wu, Xianghua, Wang, Huijie, Lai, Songtao, Wang, Jialei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518037/
https://www.ncbi.nlm.nih.gov/pubmed/37750088
http://dx.doi.org/10.1002/mco2.385
_version_ 1785109424939991040
author Zhao, Xinmin
Wu, Xianghua
Wang, Huijie
Lai, Songtao
Wang, Jialei
author_facet Zhao, Xinmin
Wu, Xianghua
Wang, Huijie
Lai, Songtao
Wang, Jialei
author_sort Zhao, Xinmin
collection PubMed
description
format Online
Article
Text
id pubmed-10518037
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105180372023-09-25 Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA Zhao, Xinmin Wu, Xianghua Wang, Huijie Lai, Songtao Wang, Jialei MedComm (2020) Correction John Wiley and Sons Inc. 2023-09-23 /pmc/articles/PMC10518037/ /pubmed/37750088 http://dx.doi.org/10.1002/mco2.385 Text en © 2023 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correction
Zhao, Xinmin
Wu, Xianghua
Wang, Huijie
Lai, Songtao
Wang, Jialei
Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
title Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
title_full Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
title_fullStr Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
title_full_unstemmed Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
title_short Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
title_sort correction to: targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing usp14 sirna
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518037/
https://www.ncbi.nlm.nih.gov/pubmed/37750088
http://dx.doi.org/10.1002/mco2.385
work_keys_str_mv AT zhaoxinmin correctiontotargetedtherapyforcisplatinresistantlungcancerviaaptamerguidednanozinccarrierscontainingusp14sirna
AT wuxianghua correctiontotargetedtherapyforcisplatinresistantlungcancerviaaptamerguidednanozinccarrierscontainingusp14sirna
AT wanghuijie correctiontotargetedtherapyforcisplatinresistantlungcancerviaaptamerguidednanozinccarrierscontainingusp14sirna
AT laisongtao correctiontotargetedtherapyforcisplatinresistantlungcancerviaaptamerguidednanozinccarrierscontainingusp14sirna
AT wangjialei correctiontotargetedtherapyforcisplatinresistantlungcancerviaaptamerguidednanozinccarrierscontainingusp14sirna

Ejemplares similares